Alec Machiels Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

Alec Machiels is Director of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 370,761 shares of APLS, which is worth approximately $10.2 Million. The most recent transaction as insider was on Jan 01, 2022, when has been sold 4,230 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 371K

0% 3M change

0.91% 12M change

Total Value Held $10.2 Million

Alec Machiels Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 01 2022	BUY Grant, award, or other acquisition	-	4,230 Added 0.62%	673,774 Common Stock
Dec 15 2021	SELL Open market or private sale	$128,640 $42.88 p/Share	3,000 Reduced 0.45%	669,544 Common Stock
Dec 15 2021	BUY Exercise of conversion of derivative security	$8,010 $2.67 p/Share	3,000 Added 0.44%	672,544 Common Stock
Nov 15 2021	SELL Open market or private sale	$130,500 $43.5 p/Share	3,000 Reduced 0.45%	669,544 Common Stock
Nov 15 2021	BUY Exercise of conversion of derivative security	$8,010 $2.67 p/Share	3,000 Added 0.44%	672,544 Common Stock
Nov 04 2021	SELL Open market or private sale	$105,000 $35.0 p/Share	3,000 Reduced 0.45%	669,544 Common Stock
Nov 04 2021	BUY Exercise of conversion of derivative security	$8,010 $2.67 p/Share	3,000 Added 0.44%	672,544 Common Stock
Aug 16 2021	SELL Open market or private sale	$142,375 $56.95 p/Share	2,500 Reduced 0.37%	669,544 Common Stock
Aug 16 2021	BUY Exercise of conversion of derivative security	$6,675 $2.67 p/Share	2,500 Added 0.37%	672,044 Common Stock
Jul 15 2021	SELL Open market or private sale	$155,750 $62.3 p/Share	2,500 Reduced 0.37%	669,544 Common Stock
Jul 15 2021	BUY Exercise of conversion of derivative security	$6,675 $2.67 p/Share	2,500 Added 0.37%	672,044 Common Stock
Jun 15 2021	SELL Open market or private sale	$162,075 $64.83 p/Share	2,500 Reduced 0.37%	669,544 Common Stock
Jun 15 2021	BUY Exercise of conversion of derivative security	$6,675 $2.67 p/Share	2,500 Added 0.37%	672,044 Common Stock
May 14 2021	SELL Open market or private sale	$113,475 $45.39 p/Share	2,500 Reduced 0.37%	669,544 Common Stock
May 14 2021	BUY Exercise of conversion of derivative security	$6,675 $2.67 p/Share	2,500 Added 0.37%	672,044 Common Stock
Apr 21 2021	SELL Open market or private sale	$114,400 $45.76 p/Share	2,500 Reduced 0.37%	669,544 Common Stock
Apr 21 2021	BUY Exercise of conversion of derivative security	$6,675 $2.67 p/Share	2,500 Added 0.37%	672,044 Common Stock
Mar 15 2021	SELL Open market or private sale	$116,925 $46.77 p/Share	2,500 Reduced 0.37%	669,544 Common Stock
Mar 15 2021	BUY Exercise of conversion of derivative security	$6,675 $2.67 p/Share	2,500 Added 0.37%	672,044 Common Stock
Feb 16 2021	SELL Open market or private sale	$115,000 $46.0 p/Share	2,500 Reduced 0.37%	669,544 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	$6,675 $2.67 p/Share	2,500 Added 0.37%	672,044 Common Stock
Jan 15 2021	SELL Open market or private sale	$132,875 $53.15 p/Share	2,500 Reduced 0.37%	669,544 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$6,675 $2.67 p/Share	2,500 Added 0.37%	672,044 Common Stock
Dec 15 2020	SELL Open market or private sale	$130,400 $52.16 p/Share	2,500 Reduced 0.37%	669,544 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$6,675 $2.67 p/Share	2,500 Added 0.37%	672,044 Common Stock

Alec Machiels

Director

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Value

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Apellis Pharmaceuticals, Inc.

Track Activities on APLS

Account